Holding(s) in Company

Summary by AI BETAClose X

Spreadex LTD has notified CRISM Therapeutics Corporation of a change in its major holdings, with the total percentage of voting rights now standing at 2.905000% as of July 1, 2026. This comprises 2.525700% directly attached to shares, representing 2,000,000 voting rights, and an additional 0.379300% through financial instruments, specifically CFDs/Spreadbets, amounting to 300,374 voting rights. This represents a decrease from their previous holding of 3.473300%.

Disclaimer*

UK 100

Latest directors dealings